Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5170876
Max Phase: Preclinical
Molecular Formula: C54H67N5O8S2
Molecular Weight: 978.29
Associated Items:
ID: ALA5170876
Max Phase: Preclinical
Molecular Formula: C54H67N5O8S2
Molecular Weight: 978.29
Associated Items:
Canonical SMILES: CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)NCCCCCC(=O)NCCNCCCC4(c5ccccc5)OC(C)(C)c5ccccc54)cc3S(=O)(=O)[O-])c3ccc(=[N+](CC)CC)cc-3oc2c1
Standard InChI: InChI=1S/C54H67N5O8S2/c1-7-58(8-2)40-25-28-43-48(36-40)66-49-37-41(59(9-3)10-4)26-29-44(49)52(43)45-30-27-42(38-50(45)69(63,64)65)68(61,62)57-33-18-12-15-24-51(60)56-35-34-55-32-19-31-54(39-20-13-11-14-21-39)47-23-17-16-22-46(47)53(5,6)67-54/h11,13-14,16-17,20-23,25-30,36-38,55,57H,7-10,12,15,18-19,24,31-35H2,1-6H3,(H-,56,60,63,64,65)
Standard InChI Key: RPQOVOZBHWXNBF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 978.29 | Molecular Weight (Monoisotopic): 977.4431 | AlogP: 8.30 | #Rotatable Bonds: 23 |
Polar Surface Area: 173.12 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -2.40 | CX Basic pKa: 9.55 | CX LogP: 3.51 | CX LogD: 3.84 |
Aromatic Rings: 4 | Heavy Atoms: 69 | QED Weighted: 0.02 | Np Likeness Score: -0.33 |
1. Camacho-Hernandez GA, Casiraghi A, Rudin D, Luethi D, Ku TC, Guthrie DA, Straniero V, Valoti E, Schütz GJ, Sitte HH, Newman AH.. (2021) Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram., 12 (7.0): [PMID:34355183] [10.1039/D1MD00072A] |
Source(1):